← Back to Search

High-Intensity vs Moderate-Intensity Gait Training for Multiple Sclerosis

N/A
Recruiting
Research Sponsored by City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

This trial will compare the effects of high intensity interval gait training (HIIGT) to traditional moderate intensity continuous gait training (MICGT) in people with MS who have difficulty walking.

Who is the study for?
This trial is for English-speaking adults over 18 with Multiple Sclerosis who can walk for 6 minutes, even if they need a device to help them. It's not open to those with heart/lung problems, recent MS flare-ups, or other neurological/orthopedic conditions.Check my eligibility
What is being tested?
The study compares two types of walking exercises: High Intensity Interval Gait Training (fast walking with rest breaks) and Moderate Intensity Continuous Gait Training (steady slower walking), to see which is better for improving walking in people with MS.See study design
What are the potential side effects?
Potential side effects may include muscle soreness, fatigue from exercise, and an increased risk of falls during training sessions due to the physical nature of the interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6 minute walk test
Secondary outcome measures
Finctional gait assessment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
High intensity interval gait training
Group II: ControlActive Control1 Intervention
Moderate intesnity continuous gait training

Find a Location

Who is running the clinical trial?

City University of New YorkLead Sponsor
17 Previous Clinical Trials
5,623 Total Patients Enrolled

Media Library

High Intensity Interval gait training Clinical Trial Eligibility Overview. Trial Name: NCT05529498 — N/A
Multiple Sclerosis Research Study Groups: Control, Experimental
Multiple Sclerosis Clinical Trial 2023: High Intensity Interval gait training Highlights & Side Effects. Trial Name: NCT05529498 — N/A
High Intensity Interval gait training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05529498 — N/A
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05529498 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participants in this experiment?

"This clinical trial consists of 30 volunteers aged between 18 and 85. To be eligible for the study, participants must meet a few prerequisites: comprehension of the consent form to demonstrate understanding of what is being tested; a diagnosis with multiple sclerosis in order to evaluate the effects of intervention on people affected by MS; an ability to move unassisted for 6 minutes as this serves as our primary measure for outcome; age above legal adulthood so that they can provide informed consent; and fluency in English due to lack resources available for translation."

Answered by AI

What is the current enrollment of participants in this experiment?

"Affirmative. The clinicaltrials.gov database reveals that this research project is actively seeking enrolment, having initially been posted on September 2nd 2022 and last revised on the same date. 30 volunteers are needed from a single medical facility for participation in the trial."

Answered by AI

Are enrollment slots currently available for this research endeavor?

"Correct. The information hosted on clinicaltrials.gov shows that this medical study, which was first published on the 2nd of September 2022, is still recruiting patients. 30 volunteers are to be recruited from 1 site for participation."

Answered by AI

Is this trial recruiting participants aged 45 or above?

"This clinical trial is offering spots to participants aged between 18 and 85. There are 44 trials specifically tailored for those younger than 18, while 392 studies cater towards individuals over 65 years old."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Hunter College
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+
0

Why did patients apply to this trial?

I would like to improve my gait. I would like to see if I can walk better and not fall if not using a walker.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
High Intensity Interval Gait Training in Multiple Sclerosis
Herbert Karpatkin 2022. "High Intensity Interval Gait Training in Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05529498.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top